naltrexone has been researched along with Cancer-Associated Pain in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 4 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, S; Honda, K; Nakazawa, M; Takata, K | 1 |
| Ashizawa, K; Hara, T; Ikeda, T; Ishii, K; Kamada, M; Komatsu, Y; Matsuo, K; Morishita, S; Ryu, E; Yamaguchi, M; Yamashita, H | 1 |
| Chamberlain, BH; Israel, RJ; Rhiner, M; Slatkin, NE; Stambler, N | 1 |
| Baamonde, A; González-Rodríguez, S; Lastra, A; Machelska, H; Menéndez, L; Seitz, V; Stein, C | 1 |
| Garcia, JM; Shamliyan, TA | 1 |
| Asonuma, S; Emi, Y; Fujii, M; Ikeda, M; Kajiwara, M; Kometani, T; Mori, M; Noda, Y; Ochiai, T; Shikada, Y | 1 |
| Fukumura, K; Kubota, R; Wajima, T | 1 |
| Baumrucker, SJ; Trofimovitch, D | 1 |
| Blair, HA | 1 |
3 review(s) available for naltrexone and Cancer-Associated Pain
| Article | Year |
|---|---|
Management of Opioid-Induced Constipation in Patients with Malignancy.
Topics: Analgesics, Opioid; Cancer Pain; Constipation; Enema; Gastrointestinal Agents; Gastrostomy; Humans; Laxatives; Morphinans; Naltrexone; Piperidines; Polyethylene Glycols; Practice Guidelines as Topic; Quaternary Ammonium Compounds | 2018 |
Pharmacology Update: Low-Dose Naltrexone as a Possible Nonopioid Modality for Some Chronic, Nonmalignant Pain Syndromes.
Topics: Analgesics, Non-Narcotic; Cancer Pain; Chronic Pain; Complex Regional Pain Syndromes; Diabetic Neuropathies; Dose-Response Relationship, Drug; Fibromyalgia; Humans; Naltrexone; Pain Management; Palliative Care; Quality of Life | 2019 |
Naldemedine: A Review in Opioid-Induced Constipation.
Topics: Analgesics, Opioid; Cancer Pain; Chronic Pain; Clinical Trials, Phase III as Topic; Constipation; Humans; Naltrexone; Narcotic Antagonists; Quality of Life | 2019 |
1 trial(s) available for naltrexone and Cancer-Associated Pain
| Article | Year |
|---|---|
Subcutaneous methylnaltrexone for opioid-induced constipation in advanced-illness patients with or without active cancer.
Topics: Adult; Aged; Cancer Pain; Double-Blind Method; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Induced Constipation; Outcome Assessment, Health Care; Quaternary Ammonium Compounds | 2020 |
5 other study(ies) available for naltrexone and Cancer-Associated Pain
| Article | Year |
|---|---|
Post-marketing surveillance of the safety and effectiveness of naldemedine in the management of opioid-induced constipation in patients with cancer pain in Japan.
Topics: Analgesics, Opioid; Cancer Pain; Constipation; Humans; Japan; Naltrexone; Narcotic Antagonists; Neoplasms; Opioid-Induced Constipation; Product Surveillance, Postmarketing; Prospective Studies | 2022 |
Naldemedine-induced Opioid Withdrawal Syndrome in a Patient with Breast Cancer without Brain Metastasis.
Topics: Analgesics, Opioid; Breast Neoplasms; Cancer Pain; Female; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Induced Constipation; Oxycodone; Substance Withdrawal Syndrome | 2020 |
A low pKa ligand inhibits cancer-associated pain in mice by activating peripheral mu-opioid receptors.
Topics: Analgesics, Opioid; Animals; Bone Neoplasms; Cancer Pain; Cell Line, Tumor; Fentanyl; Hydrogen-Ion Concentration; Hyperalgesia; Ligands; Male; Melanoma, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Morphinans; Naloxone; Naltrexone; Narcotic Antagonists; Piperidines; Receptors, Opioid, mu | 2020 |
[A New Twist on the Administration of Naldemedine for Opioid-Induced Constipation in an Outpatient].
Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Cancer Pain; Constipation; Diarrhea; Female; Humans; Male; Middle Aged; Naltrexone; Neoplasms; Outpatients | 2018 |
Population Pharmacokinetics and Exposure-Response Relationships of Naldemedine.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Analgesics, Opioid; Body Weight; Cancer Pain; Chronic Pain; Constipation; Creatinine; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Models, Biological; Naltrexone | 2018 |